Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Pfizer Inc       

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Pfizer Inc. : Pfizer Will Remove Claims on Breast and Colon Health From Centrum Label -Reuters

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/05/2012 | 11:26pm CEST

Pfizer Inc. (>> Pfizer Inc.) said it will remove claims that its Centrum multivitamin supplements promote breast and colon health from labels over the next six months, following a complaint by a watchdog group, Reuters reported Thursday.

The company will also revise websites and advertising for Centrum, the report said.

The report said the Center for Science in the Public Interest sent a letter to Pfizer Chief Executive Ian Read in April outlining its complaints and threatening a lawsuit if the claims weren't removed.

In a statement, Pfizer said it "disagrees with CSPI's concerns, but has agreed to make these changes in order to fully resolve the issues raised by the organization," Reuters reported.

Full story at http://www.reuters.com/article/2012/07/05/pfizer-centrum-idUSL2E8I5BR820120705

Write to [email protected]

Stocks mentioned in the article : Pfizer Inc.
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on PFIZER INC
06/28 PFIZER : Global Tyrosine Kinase Inhibitor Market 2017 - Merck, Novartis, Pfizer,..
06/28 PFIZER : breaks ground on new $236 million Chesterfield research campus
06/27 PFIZER : Breaks Ground on New R&D Facility in Chesterfield, Missouri
06/24 PFIZER : FDA To Discuss Mylotarg Again And Nabriva`s Pivotal Antibiotic Data
06/24 PFIZER : scientists devise 2-pronged attack against blood cancers
06/24 PFIZER : FDA rejects Pfizer`s Epogen biosimilar for the second time
06/24 PFIZER : US FDA rejects Pfizer`s Epogen biosimilar citing McPherson site warning
06/23 ROCHE : Why competition is key to cutting the cost of cancer drugs in South Afri..
06/23 PFIZER : Global Latanoprost Sales Market 2017 - Pfizer, Jamp Pharma, Laboratoire..
06/23 ROCHE : Why Competition Is Key to Cutting the Cost of Cancer Drugs in South Afri..
More news
Sector news : Pharmaceuticals - NEC
04:55a MYLAN : Investors call on Mylan chairman, director to step down
06/28 UK blue chips led lower by Hargreaves as strong pound takes toll
06/28DJVECTURA : In Asthma Collaboration With Novartis's Sandoz
06/28DJGLAXOSMITHKLINE : Announces US Filing For Mepolizumab
06/28DJMERCK AND : Today's Top Supply Chain and Logistics News From WSJ
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
2015 Tracking Prem Watsa's Fairfax Financial Holdings Portfolio - Q2 2015 Update
2015 Antibiotics Stocks To Benefit From 21st Century Cures Act
2015 ISIS PHARMA STOCK DROPS ON GOOD NEWS : Re-Evaluating The Bull Case
2015 DOW DOGS : 14.63% More Returns From 5 Lowest Priced As Of August 6 Per indexArb
2015 Pfizer's GL-2045 an Orphan Drug for CIDP
Advertisement
Financials ($)
Sales 2017 52 736 M
EBIT 2017 19 871 M
Net income 2017 10 814 M
Debt 2017 25 179 M
Yield 2017 3,80%
P/E ratio 2017 17,05
P/E ratio 2018 15,26
EV / Sales 2017 4,29x
EV / Sales 2018 3,99x
Capitalization 201 105 M
More Financials
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 37,4 $
Spread / Average Target 11%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Ian C. Read Chairman & Chief Executive Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Business Operations
Freda C. Lewis-Hall Chief Medical Officer & Executive Vice President
Mikael Dolsten President-Worldwide Research & Development
Ole Isacson Chief Scientific Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER INC201 105
JOHNSON & JOHNSON17.19%363 694
ROCHE HOLDING LTD.8.34%224 549
NOVARTIS11.74%222 848
PFIZER3.91%201 105
MERCK AND COMPANY10.68%179 263
More Results